SH Department of Biomedicine University Hospital Basel Related Content

Michael Roth, Research Group Leader at the University Hospital Basel explains what asthma is, its health impact and charts research landscape in the field.

Michael Roth, Research Group Leader at the University Hospital Basel & University Basel share his expertise on asthma and COPD, the most prevalent chronic inflammatory diseases of the lung globally

Prof Dr Michael Roth asks the question, Why do we fail to find disease specific indicators for chronic inflammatory lung diseases?

Michael Roth, Research Group Leader at University Hospital Basel argues for the clear need to improve the diagnosis of chronic inflammatory lung diseases

Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective

Prof Dr Michael Roth (PhD), Research Group Leader Pulmonary Cell Research at the University Hospital Basel in Switzerland explains the extent to which asthma and COPD (smoker’s lung) are the most prevalent chronic inflammatory diseases of the lung, globally

Professor Michael Roth from the Department Biomedicine & Pneumology, at the University Hospital Basel, discusses development of medication for asthma and new asthma therapies. Asthma is the most common non-communicable chronic inflammatory disease of the lung worldwide with no cure available. In the 2016 EU Symposium on the Awareness of allergic diseases it...

Michael Roth from University Hospital Basel & University Basel gives a compelling overview of research into asthma and need to develop innovative therapies to treat the disease Asthma is the most frequent common, non-communicable chronic inflammatory airway disease, which is often misdiagnosed and therefore incorrectly treated, even in industrialised countries...

Prof Dr Michael Roth (PhD) at University Hospital Basel looks at pneumology & pulmonary cell research, in this profile of the organisation's research

Michael Roth, Research Group Leader, Pulmonary Cell Research at University Hospital Basel & University Basel sheds light on inflammatory lung diseases

Prof Dr. Michael Roth, University Hospital Basel looks at how asthma therapy can reduce the effects of airway wall remodelling